Intracellular Bacterial Imprinting Enables Preservable Whole‐Cell Vaccination
Advanced Materials · 18.11.2026
DOI: 10.1002/adma.75745 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 18.11.2026. Verfasst von Xing Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science, Advanced Technology Research Institute (Jinan), Beijing Institute of Technology, Beijing, P.R. China. Die Arbeit nennt 63 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Beijing Natural Science Foundation, Shandong Provincial Natural Science Foundation.
Abstract (Originalsprache)
Whole‐tumor‐cell vaccines preserve broad tumor‐antigen repertoires, but converting living tumor cells into safe and intrinsically immunogenic vaccine substrates remains challenging. Here we generated bacteria‐imprinted tumor (BiT) cells through the controlled internalization of attenuated Salmonella and subsequently prepared them as nonproliferative cellular vaccines by freeze‐drying. Within a defined bacterial‐loading window, intracellular Salmonella induced endoplasmic reticulum stress‐associated immunogenic preprogramming while preserving tumor‐cell integrity, thereby enhancing danger‐signal exposure, antigen‐presentation capacity, and immune visibility. Freeze‐drying preserved the bacteria‐induced immunogenic imprint by retaining key molecular and functional attributes while maintaining overall cellular architecture and markedly reducing residual bacterial viability. Vaccination with freeze‐dried BiT (FD‐BiT) cells elicited coordinated innate and adaptive immune responses, including antigen‐presenting cell activation, T follicular helper‐B‐cell cooperation, and germinal‐center formation. This coordinated T–B cell response was accompanied by durable memory formation and enhanced intratumoral CD8 + T‐cell infiltration, proliferation, and functional maintenance. Accordingly, FD‐BiT reduced primary tumor establishment and pulmonary metastasis and restrained the growth of tumors that emerged despite prophylactic vaccination. These findings establish intracellular bacterial programming and freeze‐drying‐mediated imprint preservation as a cell‐engineering principle for whole‐tumor‐cell vaccination.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Life Science, Advanced Technology Research Institute (Jinan), Beijing Institute of Technology, Beijing, P.R. China.
- Institute of Pediatrics, Shenzhen Children's Hospital, Affiliated Shenzhen Children's Hospital of Shantou University Medical College, Shenzhen, P.R. China.
- State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Chemical Biology Center, Peking University, Beijing, P.R. China.
ORCID-Profile: Xing Liu, Guihong Lu, Hai-Yan Xie, Weidong Nie
Förderung
- National Key Research and Development Program of China
- Beijing Natural Science Foundation
- Shandong Provincial Natural Science Foundation
- National Science Fund for Distinguished Young Scholars
- Shenzhen Science and Technology Program
- Beijng Institute of Technology Research Fund Program for Young Scholars
- Natural Science Foundation of Beijing Municipality
- Natural Science Foundation of Shandong Province
Zitieren
APA
Liu, X., Lu, Z., Wang, W., Zhang, D., Tian, Z., Chen, J., Zhang, F., Lu, G., Xie, H. Y., & Nie, W. (2026). Intracellular Bacterial Imprinting Enables Preservable Whole‐Cell Vaccination. Advanced Materials. https://doi.org/10.1002/adma.75745
Vancouver
Liu X, Lu Z, Wang W, Zhang D, Tian Z, Chen J, et al. Intracellular Bacterial Imprinting Enables Preservable Whole‐Cell Vaccination. Advanced Materials. 2026. doi:10.1002/adma.75745
BibTeX
@article{Liu2026,
author = {Liu, Xing and Lu, Zhenyu and Wang, Weixiu and Zhang, Daining and Tian, Zhongqin and Chen, Jichuan and Zhang, Fengqi and Lu, Guihong and Xie, Hai-Yan and Nie, Weidong},
title = {Intracellular Bacterial Imprinting Enables Preservable Whole‐Cell Vaccination},
journal = {Advanced Materials},
year = {2026},
doi = {10.1002/adma.75745}
}
EUVIMED